Healthcare Triangle, Inc. (NASDAQ:HCTI) recently disclosed in a Form 8-K filing with the Securities and Exchange Commission that it received a notice from Nasdaq concerning non-compliance with listing rules. Nasdaq highlighted Healthcare Triangle’s failure to hold an annual shareholder meeting within twelve months of its fiscal year end. This non-compliance stems from the delay in the completion and filing of its Annual Report on Form 10-K due to the dismissal of its prior auditor following regulatory issues.
Healthcare Triangle is actively planning to convene its 2024 Annual Meeting of Stockholders by March 31, 2025, and will provide proxy materials in advance to shareholders of record. Nasdaq’s notice, indicating the non-compliance, does not have an immediate impact on the listing or trading of Healthcare Triangle’s common stock on the Nasdaq Capital Market.
This report contains forward-looking statements that express the company’s expectations while emphasizing the inherent uncertainties and risks involved in such projections. The company is committed to providing updates on any developments but advises against undue reliance on the forward-looking statements.
Healthcare Triangle’s Chief Financial Officer signed the report, reinforcing the company’s commitment to transparency and compliance amidst challenges related to listing standards. Investors must stay informed as the situation unfolds.
The financial news website MarketBeat reached out to Healthcare Triangle for further comment but did not receive an immediate response.
This article was generated by an automated content engine and was reviewed by a human editor prior to publication. For additional information, read Healthcare Triangle’s 8K filing here.
About Healthcare Triangle
Healthcare Triangle, Inc, a healthcare information technology company, focuses on developing solutions in the sectors of cloud services, data science, and professional and managed services for the electronic health record, and healthcare and life sciences industry. It provides a suite of software, solutions, platforms, and services that enables healthcare and pharma organizations to deliver personalized healthcare, precision medicine, advances in drug discovery, development and efficacy, collaborative research and development, respond to evidence, and accelerate their digital transformation.
Further Reading
- Five stocks we like better than Healthcare Triangle
- Buy P&G Now, Before It Sets A New All-Time High
- SAP’s Strong Momentum: A Bullish Setup for Investors
- Are These Liquid Natural Gas Stocks Ready For An Upside Bounce?
- BlackRock Breaks Records: Why the Stock Still Has Room to Run
- How to Calculate Stock Profit
- Duke vs. NRG: Which Energy Stock Will Power Higher Gains?